"Nasal Mucosa" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The mucous lining of the NASAL CAVITY, including lining of the nostril (vestibule) and the OLFACTORY MUCOSA. Nasal mucosa consists of ciliated cells, GOBLET CELLS, brush cells, small granule cells, basal cells (STEM CELLS) and glands containing both mucous and serous cells.
| Descriptor ID |
D009297
|
| MeSH Number(s) |
A04.531.520 A04.760.600 A10.615.550.760.600
|
| Concept/Terms |
Nasal Mucosa- Nasal Mucosa
- Mucosa, Nasal
- Schneiderian Membrane
- Membrane, Schneiderian
- Membranes, Schneiderian
- Schneiderian Membranes
|
Below are MeSH descriptors whose meaning is more general than "Nasal Mucosa".
Below are MeSH descriptors whose meaning is more specific than "Nasal Mucosa".
This graph shows the total number of publications written about "Nasal Mucosa" by people in this website by year, and whether "Nasal Mucosa" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 0 | 1 | 1 |
| 1999 | 1 | 0 | 1 |
| 2001 | 0 | 2 | 2 |
| 2002 | 2 | 1 | 3 |
| 2003 | 4 | 0 | 4 |
| 2004 | 0 | 1 | 1 |
| 2007 | 0 | 1 | 1 |
| 2010 | 1 | 0 | 1 |
| 2011 | 0 | 4 | 4 |
| 2012 | 0 | 1 | 1 |
| 2013 | 3 | 2 | 5 |
| 2014 | 0 | 2 | 2 |
| 2015 | 1 | 0 | 1 |
| 2016 | 2 | 2 | 4 |
| 2017 | 22 | 13 | 35 |
| 2018 | 27 | 15 | 42 |
| 2019 | 9 | 9 | 18 |
| 2020 | 9 | 15 | 24 |
| 2021 | 3 | 8 | 11 |
To return to the timeline, click here.
Below are the most recent publications written about "Nasal Mucosa" by people in Profiles.
-
Evaluation of Nasal Mucociliary Clearance Time in COVID-19 Patients. J Craniofac Surg. 2021 Nov-Dec 01; 32(8):e702-e705.
-
Oral Bacteria Combined with an Intranasal Vaccine Protect from Influenza A Virus and SARS-CoV-2 Infection. mBio. 2021 08 31; 12(4):e0159821.
-
Immune cell residency in the nasal mucosa may partially explain respiratory disease severity across the age range. Sci Rep. 2021 08 05; 11(1):15927.
-
Multimodal single-cell omics analysis identifies epithelium-immune cell interactions and immune vulnerability associated with sex differences in COVID-19. Signal Transduct Target Ther. 2021 07 30; 6(1):292.
-
SARS-CoV-2: preliminary study of infected human nasopharyngeal tissue by high resolution microscopy. Virol J. 2021 07 18; 18(1):149.
-
On-admission SARS-CoV-2 RNAemia as a single potent predictive marker of critical condition development and mortality in COVID-19. PLoS One. 2021; 16(7):e0254640.
-
Regulation of the Expression of SARS-CoV-2 Receptor Angiotensin-Converting Enzyme 2 in Nasal Mucosa. Am J Rhinol Allergy. 2022 Jan; 36(1):115-122.
-
Nasal ciliated cells are primary targets for SARS-CoV-2 replication in the early stage of COVID-19. J Clin Invest. 2021 07 01; 131(13).
-
Human Nasal and Lung Tissues Infected Ex Vivo with SARS-CoV-2 Provide Insights into Differential Tissue-Specific and Virus-Specific Innate Immune Responses in the Upper and Lower Respiratory Tract. J Virol. 2021 06 24; 95(14):e0013021.
-
Age- and airway disease related gene expression patterns of key SARS-CoV-2 entry factors in human nasal epithelia. Virology. 2021 09; 561:65-68.